Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apellis Pharmaceuticals (APLS) Treasury Shares (2020 - 2025)

Apellis Pharmaceuticals (APLS) has 5 years of Treasury Shares data on record, last reported at $547000.0 in Q4 2025.

  • For Q4 2025, Treasury Shares changed N/A year-over-year to $547000.0; the TTM value through Dec 2025 reached $547000.0, changed N/A, while the annual FY2025 figure was $547000.0, N/A changed from the prior year.
  • Treasury Shares reached $547000.0 in Q4 2025 per APLS's latest filing, down from $4.3 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $4.3 million in Q4 2023 and bottomed at $547000.0 in Q4 2025.
  • Average Treasury Shares over 4 years is $2.4 million, with a median of $2.4 million recorded in 2021.
  • Peak YoY movement for Treasury Shares: soared 191.59% in 2022, then grew 20.41% in 2023.
  • A 4-year view of Treasury Shares shows it stood at $1.2 million in 2021, then skyrocketed by 191.59% to $3.6 million in 2022, then grew by 20.41% to $4.3 million in 2023, then tumbled by 87.28% to $547000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $547000.0 in Q4 2025, $4.3 million in Q4 2023, and $3.6 million in Q4 2022.